 | Up a level |
Neary, M 
ORCID: 0000-0002-4960-2139, Box, H, Sharp, J, Tatham, L ORCID: 0000-0001-9448-8876, Curley, P ORCID: 0000-0003-4596-2708, Herriott, J, Kijak, E, Arshad, U ORCID: 0000-0003-1586-1885, Hobson, JJ ORCID: 0000-0003-2551-1774, Rajoli, Rkr ORCID: 0000-0002-6015-5712 et al (show 8 more authors)
(2021)
Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters.
[Preprint]
Tatham, L ORCID: 0000-0001-9448-8876, Savage, A, Rannard, S ORCID: 0000-0002-6946-1097 and Owen, A ORCID: 0000-0002-9819-7651
(2017)
Maraviroc Solid Drug Nanoparticles with Improved Oral Pharmacokinetics.
In: British Society for Nanomedicine, Queens University Belfast.
Tatham, L ORCID: 0000-0001-9448-8876, Savage, Alison C ORCID: 0000-0002-5312-9946, Dwyer, AB, Siccardi, M ORCID: 0000-0002-3539-7867, Scott, Trevor, Vourvahis, Manoli, Rannard, SP ORCID: 0000-0002-6946-1097 and Owen, A ORCID: 0000-0002-9819-7651
(2018)
Maraviroc solid drug nanoparticles with improved oral pharmacokinetics.
In: CROI, 2018-3-4 - 2018-3-7, Boston MA.
Tatham, L ORCID: 0000-0001-9448-8876, Ford, J, Rogers, H, Rannard, S ORCID: 0000-0002-6946-1097 and Owen, A ORCID: 0000-0002-9819-7651
(2016)
Surface-Dependent Mechanism for Transcellular Permeation of Polymeric Nanoparticles Across Intestinal Monolayers.
In: Controlled Release Society Annual Meeting & Exposition, 2016-7-17 - 2016-7-21, Seattle, Washington.
Tatham, L ORCID: 0000-0001-9448-8876, Dwyer, AB, Savage, Alison C ORCID: 0000-0002-5312-9946, Siccardi, M ORCID: 0000-0002-3539-7867, Scott, Trevor, Vourvahis, Manoli, Rannard, SP ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2018)
Towards a Long-Acting Injectable (LAI) Formulation For Maraviroc.
In: CROI, 2018-3-4 - 2018-3-7, Boston MA.